Get started
PHARMANIAGA BHDPHARMANIAGA BHDPHARMANIAGA BHD

PHARMANIAGA BHD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PHARMA chart


Full chart

PHARMA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪345.90 M‬ MYR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
2.570
Basic EPS (TTM)
0.090 MYR
Net income (FY)
‪131.82 M‬ MYR
Revenue (FY)
‪3.76 B‬ MYR
Shares float
‪594.91 M‬
Beta (1Y)
1.06

About PHARMANIAGA BHD


Sector
Distribution Services
Industry
Medical Distributors
CEO
Zulkifli bin Jafar
Website
pharmaniaga.com
Headquarters
Shah Alam
Founded
1994
ISIN
MYL7081OO002
FIGI
BBG000DFCJ24
Pharmaniaga Bhd. operates as an investment holding company. It engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. The firm operates through the following segments: Logistics and Distribution, Manufacturing, and Manufacturing and Distribution. The Logistics and Distribution segment engages in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment manufactures pharmaceutical products in Malaysia. The Manufacturing and Distribution segment manufactures and distributes pharmaceutical and medical products in Indonesia. The company was founded in 1994 and is headquartered in Shah Alam, Malaysia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PHARMA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PHARMA.

Frequently Asked Questions


The current price of PHARMA is 0.240 MYR — it has increased by 2.13% in the past 24 hours. Watch PHARMANIAGA BHD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MYX exchange PHARMANIAGA BHD stocks are traded under the ticker PHARMA.
PHARMA stock has risen by 11.63% compared to the previous week, the month change is a 4.35% rise, over the last year PHARMANIAGA BHD has showed a −29.41% decrease.
We've gathered analysts' opinions on PHARMANIAGA BHD future price: according to them, PHARMA price has a max estimate of 0.48 MYR and a min estimate of 0.48 MYR. Watch PHARMA chart and read a more detailed PHARMANIAGA BHD stock forecast: see what analysts think of PHARMANIAGA BHD and suggest that you do with its stocks.
PHARMA reached its all-time high on Apr 28, 2015 with the price of 1.505 MYR, and its all-time low was 0.180 MYR and was reached on Mar 23, 2020. View more price dynamics on PHARMA chart.
See other stocks reaching their highest and lowest prices.
PHARMA stock is 2.13% volatile and has beta coefficient of 1.06. Track PHARMANIAGA BHD stock price on the chart and check out the list of the most volatile stocks — is PHARMANIAGA BHD there?
Today PHARMANIAGA BHD has the market capitalization of ‪345.90 M‬, it has increased by 17.07% over the last week.
Yes, you can track PHARMANIAGA BHD financials in yearly and quarterly reports right on TradingView.
PHARMANIAGA BHD is going to release the next earnings report on May 16, 2025. Keep track of upcoming events with our Earnings Calendar.
PHARMA net income for the last quarter is ‪2.35 M‬ MYR, while the quarter before that showed ‪101.03 M‬ MYR of net income which accounts for −97.68% change. Track more PHARMANIAGA BHD financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMANIAGA BHD EBITDA is ‪304.05 M‬ MYR, and current EBITDA margin is 8.04%. See more stats in PHARMANIAGA BHD financial statements.
Like other stocks, PHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMANIAGA BHD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMANIAGA BHD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMANIAGA BHD stock shows the sell signal. See more of PHARMANIAGA BHD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.